vorinostat has been researched along with Adenocystic Carcinoma in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vorinostat is a histone deacetylase inhibitor (HDACi)." | 2.84 | A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma. ( Barrett, MT; Boerner, SA; Casetta, L; Chao, J; Chen, A; Goncalves, PH; Hansen, AR; Heilbrun, LK; Kummar, S; Lenkiewicz, E; LoRusso, PM; Malasi, S; Piekarz, RL; Pilat, MJ; Siu, LL; Smith, DW; Sukari, AW, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goncalves, PH | 1 |
| Heilbrun, LK | 1 |
| Barrett, MT | 1 |
| Kummar, S | 1 |
| Hansen, AR | 1 |
| Siu, LL | 1 |
| Piekarz, RL | 1 |
| Sukari, AW | 1 |
| Chao, J | 1 |
| Pilat, MJ | 1 |
| Smith, DW | 1 |
| Casetta, L | 1 |
| Boerner, SA | 1 |
| Chen, A | 1 |
| Lenkiewicz, E | 1 |
| Malasi, S | 1 |
| LoRusso, PM | 1 |
1 trial available for vorinostat and Adenocystic Carcinoma
| Article | Year |
|---|---|
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.
Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Chromatin Assembly and Disassembly; Exome Sequencing; Female | 2017 |